About Semler Scientific
Semler Scientific, Inc. develops, manufactures and markets innovative products and services that support the early detection and treatment of chronic diseases.
Our flagship product, QuantaFlo®, is a patented, FDA-cleared point-of-care product that measures arterial blood flow in the extremities and provides results in a matter of minutes. QuantaFlo supports health care providers in the early diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD) and heart dysfunction (HD), even in patients who are asymptomatic.
Semler Scientific History
of Accomplishments
Dr. Herbert J. Semler cofounded Semler Scientific.
Received FDA 510K clearance for first PAD system.
Received FDA Clearance and ANSI Accreditation for QuantaFlo.
Recognized in Deloitte’s Technology Fast 500.
Received HITRUST 9.1 certification.
Reached milestone of 1,000,000 QuantaFlo tests performed.
Received HITRUST 9.2 certification.
Introduced SemlerShield, SemlerVault, and SemlerAnalytics.
Recognized in Deloitte’s Technology Fast 500 for third consecutive year.
Launched first ANAB accredited certificate program for SemlerSimulation online training.
Launched QuantaFlo HD module.
Received HITRUST 9.6 certification.
Recognized in Forbes Top 100 Small Small-Cap list.
Introduced cloud-based computing for QuantaFlo software.
Leadership
Doug Murphy-Chutorian
Chief Executive Officer
Doug Murphy-Chutorian
Chief Executive Officer
Dr. Douglas Murphy-Chutorian has served as a member of our board of directors since September 2012 and as our Chief Executive Officer since October 2012 (with a brief hiatus in April, 2023). He has had a broad, diverse career in healthcare over the past 30 years in numerous positions including clinician, academician, inventor, entrepreneur, CEO, chairman of the board, and consultant to financial firms. From 2005 to 2012, he was the managing director of Select Healthcare Capital, LLC. Dr. Murphy-Chutorian is a named inventor on more than 30 patents and has guided more than 50 products through various regulatory approval processes. His business career has included extensive involvement in all facets of the medical industry from financial, research and development, manufacturing, marketing and sales, regulatory, reimbursement, and clinical trials. His breadth of healthcare experience includes all major sectors of the industry: medical devices, health services, pharmaceuticals, biotechnology, and managed care. Dr. Murphy-Chutorian received his B.A. and M.D. from Columbia University. He completed his internal medicine residency at New York University/Bellevue Medical Center and his fellowship in cardiology at Stanford University Medical Center. He has served as a faculty member in interventional cardiology at both Stanford and Montefiore Medical Centers.
Jennifer Oliva Herrington
Chief Operations Officer
Jennifer Oliva Herrington
Chief Operations Officer
As our Chief Operations Officer, Jennifer Oliva Herrington plays an integral part in the strategic vision of our company. She has over 25 years of healthcare experience with hospitals, provider networks, and insurance agencies. Having first joined Semler in October of 2010, Jennifer has a profound knowledge of contracting, implementations, and support networks. Executing the technical and clinical support initiatives, allowed Semler to provide best-in-class programs for our customers and partners. As our Chief Operations Officer, Jennifer is committed to supporting and implementing Semler’s vision across the organization. She is focused on deploying this vision into daily operations to meet Semler’s objectives. In her current role, she has oversight of Operations in addition to Revenue, Marketing, Clinical Research, Customer Education, and Technical Support. Prior to joining Semler, Jennifer used her background in medical science to gain expertise in the fields of trauma, aesthetics, and veterinary medicine.
Renae Cormier
Chief Financial Officer
Renae Cormier
Chief Financial Officer
Renae Cormier joined Semler in May 2022. As our Chief Financial Officer, she leads our accounting, finance, investor relations, and business strategy efforts, and she plays a pivotal role in shaping the overall direction of the company. Renae has extensive experience with investing, finance, and accounting. Prior to joining Semler, she held numerous positions with investment management firms. Most recently she was a partner at Aravt Global from 2013 to 2022 where she was responsible for allocating investment capital in public and private companies across a variety of industries, as well as leading accounting-focused risk management across the portfolio’s holdings. From 1997 to 2001, Renae was an auditor and provided mergers and acquisitions transaction advisory services at PricewaterhouseCoopers.
Shane Reid
Chief Technology Officer
Shane Reid
Chief Technology Officer
Shane Reid is our Chief Technology Officer. He brings a wide-ranging experience as an engineer and manager from the small startups to large, multi-divisional organizations. Shane has demonstrated success in both primary technology development and application of technology to meet vertical market business needs. He loves building teams of talented people and guiding them as they use technology and innovation to solve real world problems. Shane leads our team of engineers and IT professionals that deliver mobile and desktop applications, hardware, healthcare system interconnections and cloud-based services, all in support of Semler’s mission to be a leader in medical risk-assessment.
